Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ines Lohse

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Anticancer Research|April 3, 2020
Pathogenesis and Treatment of Pancreatic Cancer Related PainInes Lohse, Shaun P Brothers
Plos One|October 1, 2011
The CPT1C 5'UTR contains a repressing upstream open reading frame that is regulated by cellular energy availability and AMPKInes Lohse, Patrick Reilly, Kathrin Zaugg
Oncotarget|November 22, 2018
Naturally occurring compounds as pancreatic cancer therapeuticsInes Lohse, Erin Wildermuth, Shaun P Brothers
Molecular Cancer|March 31, 2019
mRNA-to-protein translation in hypoxiaNancy T Chee, Ines Lohse, Shaun P Brothers
Cancer Letters|December 4, 2012
Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxiaDelphine Tamara Marie-Egyptienne, Ines Lohse, Richard Peter Hill
Oncotarget|February 1, 2019
Precision medicine in the treatment stratification of AML patients: challenges and progressInes Lohse, Kurt Statz-Geary, Shaun P Brothers, et al.
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical ResearchJessica L Dennison, Natalie R Ricciardi, Ines Lohse, et al.
Biomolecules|September 28, 2023
Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD MouseJessica Dennison, Armando Mendez, Angela Szeto, et al.
Cancers|June 26, 2026
The Role of AXL Signaling and Mutant <i>Isocitrate Dehydrogenase 1/2</i> in Conventional ChondrosarcomaMatthew Chu, Zacharias Barron, Sila Basbay, et al.
Oncotarget|December 1, 2016
Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenograftsInes Lohse, Jacqueline Mason, Pinjiang Mary Cao, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Anticancer Research|April 3, 2020
Pathogenesis and Treatment of Pancreatic Cancer Related PainInes Lohse, Shaun P Brothers
Plos One|October 1, 2011
The CPT1C 5'UTR contains a repressing upstream open reading frame that is regulated by cellular energy availability and AMPKInes Lohse, Patrick Reilly, Kathrin Zaugg
Oncotarget|November 22, 2018
Naturally occurring compounds as pancreatic cancer therapeuticsInes Lohse, Erin Wildermuth, Shaun P Brothers
Molecular Cancer|March 31, 2019
mRNA-to-protein translation in hypoxiaNancy T Chee, Ines Lohse, Shaun P Brothers
Cancer Letters|December 4, 2012
Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxiaDelphine Tamara Marie-Egyptienne, Ines Lohse, Richard Peter Hill
Oncotarget|February 1, 2019
Precision medicine in the treatment stratification of AML patients: challenges and progressInes Lohse, Kurt Statz-Geary, Shaun P Brothers, et al.
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical ResearchJessica L Dennison, Natalie R Ricciardi, Ines Lohse, et al.
Biomolecules|September 28, 2023
Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD MouseJessica Dennison, Armando Mendez, Angela Szeto, et al.
Cancers|June 26, 2026
The Role of AXL Signaling and Mutant <i>Isocitrate Dehydrogenase 1/2</i> in Conventional ChondrosarcomaMatthew Chu, Zacharias Barron, Sila Basbay, et al.
Oncotarget|December 1, 2016
Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenograftsInes Lohse, Jacqueline Mason, Pinjiang Mary Cao, et al.
Pageof 4